<DOC>
	<DOC>NCT00150202</DOC>
	<brief_summary>This study will examine the efficacy and safety of pegaptanib sodium in Japanese patients with wet-type AMD, in order to establish that there is no large difference in the efficacy and the safety of the drug between Western and Japanese patients.</brief_summary>
	<brief_title>Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<criteria>Wet AMD, Visual Acuity from 20/320 to 20/40 Diabetic retinopathy, laser coagulation history</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
</DOC>